American Society of Clinical Oncology

SHERPA: White

People

  1. Reidy
    Reidy
  2. Saltz
    Saltz
  3. Cercek Hanjis
    Cercek Hanjis
  4. Raj
    Raj
  5. Segal
    Segal
  6. Stadler
    Stadler
  7. Yaeger
    Yaeger
  8. Weiser
    Weiser
  9. Chou
    Chou
  10. Capanu
    Capanu

Groups

  1. Center for Pancreatic Cancer Research (92)
  2. Department of Medicine (92)
  3. Gastrointestinal Oncology Service (92)
  4. Solid Tumor Oncology Division (92)
  5. Survivorship Research (38)
  6. Surgery (28)
  7. Population Sciences Research Program (25)
  8. Epidemiology and Biostatistics (23)
  9. Nursing (23)
  10. Biostatistics Service (22)
Search Within
  1. "Gastrointestinal Oncology Service"
  2. "Diane Reidy"
Formats
  1. Meeting Abstract (79)
  2. Journal Article (13)
Groups
  1. Center for Pancreatic Cancer Research (92)
  2. Department of Medicine (92)
  3. Gastrointestinal Oncology Service (92)
  4. Solid Tumor Oncology Division (92)
  5. Survivorship Research (38)
  6. Surgery (28)

More Groups

People
  1. Diane Reidy (92)
  2. Leonard Saltz (41)
  3. Andrea Cercek Hanjis (24)
  4. Nitya Raj (24)
  5. Neil Segal (23)
  6. Zsofia Stadler (18)

More People

Years
  1. 2023 (3)
  2. 2022 (6)
  3. 2021 (6)
  4. 2020 (4)
  5. 2019 (10)
  6. 2018 (11)

More Years

Publications
  1. Journal of Clinical Oncology (86)
  2. JCO Clinical Cancer Informatics (3)
  3. Journal of Oncology Practice (2)
  4. JCO Precision Oncology (1)

Results (92)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient portals to elicit essential patient-reported elements of communication supporting person-centered oncologic care: A pilot study of the PERSON Approach
    Journal Article

    Epstein, A. S.; Knezevic, A.; Romano, D. R.; Hoque, A.; Raj, N.; Reidy, D.; Rosa, W. E.; Cruz, E.; Calderon, C.; O'Shaughnessy, S.; more...
    JCO Clinical Cancer Informatics (2023)

    Fulltext@MSK | Save
  • Genetic profiling analysis design of well-differentiated aggressive grade 2 and 3 gastroenteropancreatic neuroendocrine tumors in the phase III randomized controlled COMPOSE trial
    Meeting Abstract

    Halfdanarson, T. R.; Capdevila, J.; Halperin, D. M.; Herrmann, K.; Kong, G.; Leyden, S.; Mailman, J.; Reidy-Lagunes, D.; Srirajaskanthan, R.; Erdòˆ, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)
    Meeting Abstract

    Cowzer, D.; Shah, R. H.; Punn, S.; Fiedler, L.; DeMore, A.; Chou, J. F.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; Raj, N. P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211)
    Meeting Abstract

    Kunz, P. L.; Graham, N.; Catalano, P. J.; Nimeiri, H.; Fisher, G. A.; Longacre, T. A.; Suarez, C. J.; Rubin, D.; Yao, J. C.; Kulke, M. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade
    Meeting Abstract

    Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy
    Meeting Abstract

    Daly, R. M.; Nicholas, K.; Flynn, J.; Panageas, K.; Silva, N.; Duck, E.; Zervoudakis, A.; Holland, J. C.; Salvaggio, R.; Begue, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early-onset well differentiated pancreatic neuroendocrine tumors: Clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C. A.; Reidy, D. L.; Wei, A. C. C.; Raj, N. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of neuroendocrine neoplasms treated with immune checkpoint inhibitors: A single-institution experience
    Meeting Abstract

    Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Pivotal phase III COMPOSE trial will compare (177)Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors
    Meeting Abstract

    Halfdanarson, T. R.; Reidy, D. L.; Vijayvergia, N.; Halperin, D. M.; Goldstein, G.; Kong, G.; Michael, M.; Leyden, S.; Grozinsky-Glasberg, S.; Sorbye, H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part B (pembrolizumab plus chemotherapy)
    Meeting Abstract

    Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Dhawan, M. S.; Fattah, D.; Fong, L.; Grabowsky, J.; Hope, T. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save